Co-expression of GPR30 and ERβ and their association with disease progression in uterine carcinosarcoma

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 3, 2010, Pages 242.e1-242.e5

  Huang, Gloria S ^a   Gunter, Marc J ^a   Arend, Rebecca C ^a   Li, Maomi ^a   Arias Pulido, Hugo ^b   Prossnitz, Eric R ^b   Goldberg, Gary L ^a   Smith, Harriet O ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

estrogen receptor; G protein coupled receptor 30; uterine carcinosarcoma

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; PROGESTERONE RECEPTOR; PROTEIN ANTIBODY;

ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANK SUM TEST; TISSUE MICROARRAY; UTERINE CARCINOSARCOMA; UTERUS CARCINOMA;

EID: 77956338272     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.04.046     Document Type: Article

References (26)

1. S.G. Silverberg, F.J. Major, and J.A. Blessing Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a gynecologic oncology group pathologic study of 203 cases Int J Gynecol Pathol 9 1990 1 19
2. F. Amant, V. Vloeberghs, and H. Woestenborghs ERBB-2 gene overexpression and amplification in uterine sarcomas Gynecol Oncol 95 2004 583 587
3. Y. Yildirim, M.M. Inal, and M. Sanci Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases Int J Gynecol Cancer 15 2005 1239 1242
4. M. Arenas, A. Rovirosa, and V. Hernandez Uterine sarcomas in breast cancer patients treated with tamoxifen Int J Gynecol Cancer 16 2006 861 865
5. G.S. Huang, L.G. Chiu, and J.S. Gebb Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma Gynecol Oncol 107 2007 513 517
6. A.W. Brandenberger, M.K. Tee, J.Y. Lee, V. Chao, and R.B. Jaffe Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus J Clin Endocrinol Metab 82 1997 3509 3512
7. A. Bardin, N. Boulle, G. Lazennec, F. Vignon, and P. Pujol Loss of ERbeta expression as a common step in estrogen-dependent tumor progression Endocr Relat Cancer 11 2004 537 551
8. O.W. Yap, G. Bhat, L. Liu, and T.O. Tollefsbol Epigenetic modifications of the estrogen receptor beta gene in epithelial ovarian cancer cells Anticancer Res 29 2009 139 144
9. K.F. Koehler, L.A. Helguero, L.-A. Haldosn, M. Warner, and J.-A. Gustafsson Reflections on the discovery and significance of estrogen receptor beta Endocr Rev 26 2005 465 478
10. S.E. Bulun Endometriosis N Engl J Med 360 2009 268 279
11. E. Trukhacheva, Z. Lin, S. Reierstad, Y.H. Cheng, M. Milad, and S.E. Bulun Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis J Clin Endocrinol Metab 94 2009 615 622
12. G.S. Huang, R.C. Arend, and M. Li Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma Am J Obstet Gynecol 200 2009 457.e1 457.e5
13. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 2005 1625 1630
14. E.R. Prossnitz, and M. Maggiolini Mechanisms of estrogen signaling and gene expression via GPR30 Mol Cell Endocrinol 308 2009 32 38
15. E.J. Filardo, J.A. Quinn, K.I. Bland, and A.R. Frackelton Jr Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol Endocrinol 14 2000 1649 1660
16. E.R. Prossnitz, J.B. Arterburn, H.O. Smith, T.I. Oprea, L.A. Sklar, and H.J. Hathaway Estrogen signaling through the transmembrane G protein-coupled receptor GPR30 Annu Rev Physiol 70 2008 165 190
17. H.O. Smith, K.K. Leslie, and M. Singh GPR30: a novel indicator of poor survival for endometrial carcinoma Am J Obstet Gynecol 196 2007 386.e1 386.e11
18. E.J. Filardo, C.T. Graeber, and J.A. Quinn Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression Clin Cancer Res 12 2006 6359 6366
19. H. Smith, H. Arias-Pulido, and D. Kuo GPR30 predicts poor survival for ovarian cancer Gynecol Oncol 114 2009 465 471
20. B.J. Plante, L. Yuan, B.A. Lessey, and S.L. Young Regulation and signaling of the membrane estrogen receptor, GPR30, in human endometrial cells Reprod Sci 15 2008 70A
21. P.A. Hershberger, L.P. Stabile, and B. Kanterewicz Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells J Steroid Biochem Mol Biol 116 2009 102 109
22. A. Vivacqua, R. Lappano, and P. De Marco G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells Mol Endocrinol 23 2009 1815 1826
23. L. Albanito, D. Sisci, and S. Aquila Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells Endocrinology 149 2008 3799 3808
24. A. Schipf, D. Mayr, T. Kirchner, and J. Diebold Molecular genetic aberrations of ovarian and uterine carcinosarcomasa CGH and FISH study Virchows Arch 452 2008 259 268
25. D.P. Pandey, R. Lappano, L. Albanito, A. Madeo, M. Maggiolini, and D. Picard Estrogenic GPR30 signaling induces proliferation and migration of breast cancer cells through CTGF EMBO J 28 2009 523 532
26. M.K. Dennis, R. Burai, and C. Ramesh In vivo effects of a GPR30 antagonist Nat Chem Biol 5 2009 421 427